Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.18 +0.01 (+0.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Current Leases (2019)

Updated

Chemomab Therapeutics' Current Leases was $505,000 in Q3 2019, up 4.3% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Current Leases (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 505,000.00
Jun 30, 2019 484,000.00
API Access

Chemomab Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CMMB&period=max&api_key=YOUR_API_KEY